InsidersTradesSigma
Follow the CERNER Corp stock price and the full management transaction log of the company, a listed equity based in United States. Shares are quoted on the US market, under the oversight of SEC (Form 4). Operating in the Healthcare & Pharma sector, CERNER Corp has published 54 reports. The latest transaction was reported on 9 June 2022 (U). Among the most active insiders: Battaglioli Michael R.. Every trade is free.
54
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€2m
3 ops.
Sell Volume
30Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 9 June 2022
Declarations54 total
6,246 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035508:0
371 shares@ US$95.008.2% of flowCommon StockSEC:0001209191-22-035484:0
21,909 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035500:0
2,768 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035498:0
844 shares@ US$95.005.3% of flowCommon StockSEC:0001209191-22-035502:0
539 shares@ US$95.0015.5% of flowCommon StockSEC:0001209191-22-035488:0
37,460 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035491:0
23,438 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035499:0
12,825 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035503:0
43,905 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035493:0
295 shares@ US$95.002.2% of flowCommon StockSEC:0001209191-22-035492:0
26,588 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035504:0
15,032 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035497:0
14,525 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035501:0
31,319 shares@ US$95.00100.0% of flowCommon StockSEC:0001209191-22-035495:0
2,000 shares@ US$55.7426.1% of flowCommon StockSEC:0001209191-22-027636:0
1,729 shares0Common StockSEC:0001209191-22-026575:0
7,769 shares@ US$93.4046.9% of flowCommon StockSEC:0001209191-22-018181:0
15,000 shares@ US$67.2477.7% of flowCommon StockSEC:0001209191-22-017043:0
7,374 shares0Common StockSEC:0001209191-21-071600:0
4,509 shares0Common StockSEC:0001209191-21-070948:0
4,509 shares0Common StockSEC:0001209191-21-070941:0
4,407 shares0Common StockSEC:0001209191-21-070953:0
11,480 shares0Common StockSEC:0001209191-21-070954:0
5,549 shares0Common StockSEC:0001209191-21-070956:0
25 of 54 declarations
About CERNER Corp
Recent developments are dominated by post-acquisition integration rather than standalone corporate actions. Oracle has been repositioning the Cerner asset base under the Oracle Health banner, with a focus on cloud modernization, AI-enabled clinical tools, and tighter integration with Oracle’s broader data and application stack. In practical terms, that means Cerner’s former strategic themes—EHR modernization, workflow automation, interoperability, and hospital digitization—now sit inside Oracle’s healthcare strategy rather than a separate public company. As a result, SEC Form 4 insider-trading activity is associated with Oracle, not Cerner as an independent issuer. For French, Belgian, and Swiss investors, Cerner is best viewed as a historically important U.S. healthcare software franchise that has been folded into a much larger NASDAQ-listed parent, rather than as a separately traded stock.
